Medtronic (MDT) Shares Outstanding (2013 - 2026)
Medtronic (MDT) reported Shares Outstanding (Entity) of $1.3 billion for Q2 2026, little changed on a YoY basis from $1.3 billion in Q2 2025, and little changed sequentially from $1.3 billion in Q1 2026.
Medtronic (MDT) Shares Outstanding (2013 - 2026) Analysis & Trends
Medtronic (MDT) has 14 years of Shares Outstanding (Entity) data on file, last reported at $1.3 billion in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) changed 0.14% year-over-year to $1.3 billion; the trailing twelve-month figure through Apr 2026 stood at $1.3 billion (changed 0.14% YoY), and the FY2026 full-year result was $1.3 billion, changed 0.14% from the prior year.
- Shares Outstanding (Entity) steadied at $1.3 billion in Q2 2026, from $1.3 billion in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $1.3 billion in Q1 2022 to a low of $1.3 billion in Q2 2026.
- A 5-year average of $1.3 billion and a median of $1.3 billion in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) rose 0.09% in 2023 and slipped 3.61% in 2024, its largest moves.
- Tracing MDT's Shares Outstanding (Entity) over 5 years: stood at $1.3 billion in 2022, then climbed by 0.0% to $1.3 billion in 2023, then dropped by 3.58% to $1.3 billion in 2024, then fell by 0.04% to $1.3 billion in 2025, then slipped by 0.14% to $1.3 billion in 2026.
- Business Quant data shows MDT's Shares Outstanding (Entity) at $1.3 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.3 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 98.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 1.28 Bn |
| Jan 23, 2026 | 1.28 Bn |
| Oct 24, 2025 | 1.28 Bn |
| Jul 25, 2025 | 1.28 Bn |
| Apr 25, 2025 | 1.29 Bn |
| Jan 24, 2025 | 1.28 Bn |
| Oct 25, 2024 | 1.28 Bn |
| Jul 26, 2024 | 1.29 Bn |
| Apr 26, 2024 | 1.33 Bn |
| Jan 26, 2024 | 1.33 Bn |
| Oct 27, 2023 | 1.33 Bn |
| Jul 28, 2023 | 1.33 Bn |
| Apr 28, 2023 | 1.33 Bn |
| Jan 27, 2023 | 1.33 Bn |
| Oct 28, 2022 | 1.33 Bn |
| Jul 29, 2022 | 1.33 Bn |
| Apr 29, 2022 | 1.34 Bn |
| Jan 28, 2022 | 1.34 Bn |
| Oct 29, 2021 | 1.35 Bn |
| Jul 30, 2021 | 1.34 Bn |